The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
July 7th 2025
Y-90 resin microspheres offer a new option for patients with liver cancer for the treatment of unresectable hepatocellular carcinoma.
Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB
May 3rd 2025In chronic hepatitis B (CHB) mouse models, the ferritin nanoparticle-preS1 (ferritin-NP-preS1) with small interfering RNA (siRNA) showed 100% and sustained serum HBsAg over an approximate 11-month period.
Read More
Practical Advice for Perioperative Management of Patients With Harmful Alcohol Intake
March 7th 2025A team of clinical and academic experts from the Association of Anaesthetists produced a consensus statement outlining the key components to minimizing the impact of harmful alcohol intake in the surgical population.
Read More
Mitochondrial Dysfunction Present in Visceral Adipose Tissue in Patients With Obesity-Related MASH
January 29th 2025The authors note that this may cause disruptions in the metabolic stability of lipid processing and storage, impacting the liver and accelerating damaging adaptative responses.
Read More